
    
      Protocol description

      Visit D0

        -  patient inclusion after informed signed consent

        -  clinical exam

        -  blood sampling (magnesium dosage)

        -  questionnaires (neuropathic pain and quality of life)

        -  daily self-evaluation on neuropathic pain scale (Week0 to Week5)

      D8 : first intake of study drug (magnesium or placebo)

      Visit Week5:

        -  questionnaires (neuropathic pain and quality of life)

        -  blood sampling (magnesium dosage)

        -  clinical exam
    
  